Can an intrathecal, catheter-tip-associated inflammatory mass reoccur?

Clinical Journal of Pain

Volumn 26, Issue 7, 2010, Pages 631-634

  De Andrés, José ^a   Palmisani, Stefano ^a   Villanueva Pérez, Vicente L ^b   Asensio, Juan ^a   López Alarcón, Maria Dolores ^a  

^a HOSPITAL GENERAL UNIVERSITARIO DE VALENCIA   (Spain)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

chronic pain; granuloma; inflammatory mass; intrathecal infusion; opioid infusion; reoccurrence

Indexed keywords

MORPHINE; OPIATE DERIVATIVE;

ADULT; ARTICLE; CASE REPORT; CATHETER; CHRONIC PAIN; GRANULOMA; HUMAN; INFLAMMATION; MALE; PRIORITY JOURNAL; RECURRENCE RISK;

EID: 77955984336     PISSN: 07498047     EISSN: 15365409     Source Type: Journal    
DOI: 10.1097/AJP.0b013e3181e4a541     Document Type: Article

References (23)

1. North R, Cutchis P, Epstein J, et al. Spinal cord compression complicating subarachnoid infusion of morphine: case report and laboratory experience. Neurosurgery. 1991;29:778-784.
2. Miele VJ, Price KO, Bloomfield S, et al. A review of intrathecal morphine therapy related granulomas. Eur J Pain. 2006;10: 251-261.
3. Gradert TL, Baze WB, Satterfield WC, et al. Safety of chronic intrathecal morphine infusion in a sheep model. Anesthesiol-ogy. 2003;99:188-198.
4. Allen JW, Horais KA, Tozier NA, et al. Opiate pharmacology of intrathecal granulomas. Anesthesiology. 2006;105:590-598.
5. Yaksh TL, Hassenbusch S, Burchiel K, et al. Inflammatory masses associated with intrathecal drug infusion: a review of preclinical evidence and human data. Pain Med. 2002;3: 300-312.
6. Allen JW, Horais KA, Tozier NA, et al. Time course and role of morphine dose and concentration in intrathecal granuloma formation in dogs: a combined magnetic resonance imaging and histopathology investigation. Anesthesiology. 2006;105: 581-589.
7. Deer TR, Raso LJ, Coffey RJ, et al. Intrathecal baclofen and catheter tip inflammatory mass lesions (granulomas): a reevaluation of case reports and imaging findings in light of experimental, clinicopathological, and radiological evidence. Pain Med. 2008;9:391-395.
8. Monsalve V, De Andres J, Valia J. Application of a psychological decision algorithm for the selection of patients susceptible to implantation of neuromodulation systems for the treatment of chronic pain. A proposal. Neuromodulation. 2000;3:191-200.
9. Deer T, Krames E, Hassenbusch S, et al. Management of intrathecal catheter-tip inflammatory masses: an updated 2007 consensus statement from an expert panel. Neuromodulation. 2008;11:77-92.
10. Abejon D, del Saz JM, Ley L, et al. Spinal granuloma in a patient receiving a spinal infusion of morphine and clonidine (English Abstract). Rev Esp Anestesiol Reanim. 2009;56: 380-384.
11. Wallace MS, Rauck R, Fisher R, et al. Intrathecal ziconotide for severe chronic pain: safety and tolerability results of an open-label, long-term trial. Anesth Analg. 2008;106:628-637, table of contents.
12. Wang JK, Nauss LA, Thomas JE. Pain relief by intrathecally applied morphine in man. Anesthesiology. 1979;50:149-151.
13. Hassenbusch SJ, Stanton-Hicks M, Covington EC, et al. Long-term intraspinal infusions of opioids in the treatment of neuropathic pain. J Pain Symptom Manage. 1995;10:527-543.
14. Deer TR. A prospective analysis of intrathecal granuloma in chronic pain patients: a review of the literature and report of a surveillance study. Pain Physician. 2004;7:225-228.
15. Reig E, Abejon D. Continuous morphine infusion: a retrospective study of efficacy, safety and demographic variables. Neuromodulation. 2009;12:122-129.
16. McMillan MR, Doud T, Nugent W. Catheter-associated masses in patients receiving intrathecal analgesic therapy. Anesth Analg. 2003;96:186-190.
17. Coffey RJ, Burchiel K. Inflammatory mass lesions associated with intrathecal drug infusion catheters: report and observations on 41 patients. Neurosurgery. 2002;50:78-86.
18. Allen JW, Zielinska W, Cizkova D, et al. Degranulation of dural mast cells by in vivo and ex vivo opiate exposure. Toxicol Sci. 2004;78:88.
19. Yaksh TL, Horais KA, Tozier NA, et al. Chronically infused intrathecal morphine in dogs. Anesthesiology. 2003;99: 174-187.
20. Hassenbusch S, Burchiel K, Coffey RJ, et al. Management of intrathecal catheter-tip inflammatory masses: a consensus statement. Pain Med. 2002;3:313-323.
21. Deer TR, Krames E, Levy RM, et al. Practice choices and challenges in the current intrathecal therapy environment: an online survey. Pain Med. 2009;10:304-309.
22. Jourdain V, Cantin L, Prud'Homme M, et al. Intrathecal morphine therapy-related granulomas: faster to grow than thought. Neuromodulation. 2009;12:164-168.
23. Greitz D, Franck A, Nordell B. On the pulsatile nature of intracranial and spinal CSF-circulation demonstrated by MR imaging. Acta Radiol. 1993;34:321-328.